Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DDS Technologies Inc. was a development-stage company focused on the commercialization of its proprietary Dynamic Dispersion System (DDS), a mechanical bio-refining technology. The DDS platform was designed to micronize organic and inorganic materials into ultra-fine powders, facilitating the extraction of active compounds for use in the nutraceutical, pharmaceutical, and agricultural sectors. By utilizing high-velocity air streams to break down cellular structures without the use of heat or chemicals, the company aimed to preserve the integrity of heat-sensitive biological molecules. Despite initial interest in its bio-extraction capabilities, the company faced significant financial and legal challenges, eventually ceasing operations in the mid-2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DDS Technologies.